Dora Bibila, Commercialization Strategy Lead, Corval
Advertisement
Articles by Dora Bibila, Commercialization Strategy Lead, Corval
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
3
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5